Systematic Financial Management LP United Therapeutics Corp Transaction History

Systematic Financial Management LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 06, 2019	SELL	$74.85 - $85.99 $735,775 - $845,281	-9,830 Closed	0 $0
Q2 2019 Jul 26, 2019	SELL	$76.06 - $120.81 $41,833 - $66,445	-550 Reduced 5.3%	9,830 $767,000
Q1 2019 May 03, 2019	SELL	$107.15 - $126.84 $65,897 - $78,006	-615 Reduced 5.59%	10,380 $1.22 Million
Q4 2018 Feb 13, 2019	SELL	$101.4 - $128.73 $34,983 - $44,411	-345 Reduced 3.04%	10,995 $1.2 Million
Q3 2018 Nov 06, 2018	SELL	$113.81 - $129.46 $133,157 - $151,468	-1,170 Reduced 9.35%	11,340 $1.45 Million
Q2 2018 Aug 08, 2018	SELL	$101.14 - $118.31 $42,984 - $50,281	-425 Reduced 3.29%	12,510 $1.42 Million
Q1 2018 May 09, 2018	BUY	$107.21 - $151.94 $74,510 - $105,598	695 Added 5.68%	12,935 $1.45 Million
Q4 2017 Feb 09, 2018	BUY	$118.58 - $151.28 $123,916 - $158,087	1,045 Added 9.33%	12,240 $1.81 Million
Q3 2017 Nov 08, 2017	BUY	$114.6 - $136.81 $1.28 Million - $1.53 Million	11,195	11,195 $1.31 Million

671

42.4M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $17.2B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Systematic Financial Management LP, based on Form 13F filings with the SEC.

Stay updated on Systematic Financial Management LP with notifications on news.